x

Cidara Therapeutics, Inc. (Nasdaq:CDTX)

Health Care/Life Sciences • Biotechnology
CIK 1610618
Company

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Address
6310 Nancy Ridge Drive
Suite 101
San Diego, California 92121
Employees
69
Stock Info
Close
$23.50
Day Range
22.62 - 23.64
52 Week Range
10.00 - 28.42
Average volume
97.93K
Short Interest
181.99K (02/14/25)
% of Float Shorted
2.66%
Market Cap
$257.21M
Revenue
$63.91M
Net Income
-$22.93M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$25.55
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Independent Director
James Merson
Independent Director
Ryan Spencer
Director
Joshua B. Resnick
Chairman
Daniel D. Burgess
Independent Director
Chrysa Mineo
Independent Director
Theodore R. Schroeder
Independent Director
Bonnie L. Bassler
Independent Director
Carin Canale-Theakston
SEC filings
DateFormEvent
19 Dec, 2024 4
19 Dec, 2024 4
19 Dec, 2024 4
19 Dec, 2024 4
19 Dec, 2024 4
9 Dec, 2024 SC 13G
4 Dec, 2024 SC 13G
3 Dec, 2024 SC 13G
29 Nov, 2024 4
26 Nov, 2024 SC 13D/A
26 Nov, 2024 8-K
14 Nov, 2024 SC 13G/A
7 Nov, 2024 8-K
7 Nov, 2024 10-Q
2 Oct, 2024 4
2 Oct, 2024 4
2 Oct, 2024 4
2 Oct, 2024 4
2 Oct, 2024 4
23 Sep, 2024 8-K
13 Sep, 2024 4
13 Sep, 2024 4
12 Sep, 2024 8-K
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
13 Aug, 2024 S-8
31 Jul, 2024 424B3
31 Jul, 2024 EFFECT
29 Jul, 2024 SC 13G
29 Jul, 2024 UPLOAD
29 Jul, 2024 CORRESP
29 Jul, 2024 SC 13G
25 Jul, 2024 SC 13D
22 Jul, 2024 4
22 Jul, 2024 4/A
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 S-1
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 4
19 Jul, 2024 4
18 Jul, 2024 8-K
11 Jun, 2024 4
3 Jun, 2024 DEF 14A
3 Jun, 2024 DEFA14A
3 Jun, 2024 ARS
23 May, 2024 PRE 14A
20 May, 2024 8-K
15 May, 2024 10-Q
15 May, 2024 8-K
6 May, 2024 D
3 May, 2024 8-K
30 Apr, 2024 4
30 Apr, 2024 3
30 Apr, 2024 3
30 Apr, 2024 3
30 Apr, 2024 4
30 Apr, 2024 4
30 Apr, 2024 4
30 Apr, 2024 3
29 Apr, 2024 8-K/A
24 Apr, 2024 8-K
24 Apr, 2024 8-K
23 Apr, 2024 S-8
22 Apr, 2024 8-K
22 Apr, 2024 10-K
16 Apr, 2024 8-K
5 Apr, 2024 8-K
1 Apr, 2024 NT 10-K
20 Mar, 2024 4
20 Mar, 2024 4
20 Mar, 2024 4
20 Mar, 2024 4
20 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
4 Mar, 2024 DEF 14A
23 Feb, 2024 PRE 14A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
9 Feb, 2024 8-K
22 Dec, 2023 8-K
17 Nov, 2023 8-K
16 Nov, 2023 8-K
2 Nov, 2023 8-K
2 Nov, 2023 10-Q
13 Oct, 2023 8-K
21 Sep, 2023 8-K
13 Sep, 2023 4
13 Sep, 2023 4
6 Sep, 2023 8-K
14 Aug, 2023 4
8 Aug, 2023 4
3 Aug, 2023 8-K
3 Aug, 2023 10-Q
24 Jul, 2023 UPLOAD
7 Jul, 2023 CORRESP
26 Jun, 2023 UPLOAD
23 Jun, 2023 8-K
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
31 May, 2023 CORRESP
11 May, 2023 8-K
11 May, 2023 10-Q
28 Apr, 2023 UPLOAD
27 Apr, 2023 ARS
27 Apr, 2023 DEF 14A
27 Apr, 2023 DEFA14A
29 Mar, 2023 4
29 Mar, 2023 4
29 Mar, 2023 4
29 Mar, 2023 4
29 Mar, 2023 4
27 Mar, 2023 4
23 Mar, 2023 S-8
23 Mar, 2023 8-K
23 Mar, 2023 10-K
13 Mar, 2023 4
13 Mar, 2023 4
13 Mar, 2023 4
13 Mar, 2023 4
6 Mar, 2023 424B5
6 Mar, 2023 8-K
6 Mar, 2023 424B5
2 Mar, 2023 424B5
2 Mar, 2023 424B5
2 Mar, 2023 8-K
1 Mar, 2023 8-K
14 Feb, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
27 Jan, 2023 4
16 Dec, 2022 8-K
29 Nov, 2022 DEFA14A
10 Nov, 2022 DEF 14A
3 Nov, 2022 10-Q
3 Nov, 2022 8-K
31 Oct, 2022 PRE 14A
21 Oct, 2022 8-K
19 Sep, 2022 4
13 Sep, 2022 4
13 Sep, 2022 4
13 Sep, 2022 4
8 Sep, 2022 8-K CEO Change
2 Sep, 2022 8-K
9 Aug, 2022 8-K
9 Aug, 2022 10-Q
27 Jul, 2022 8-K
7 Jul, 2022 8-K
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 8-K
11 May, 2022 8-K
11 May, 2022 10-Q
29 Apr, 2022 DEF 14A
29 Apr, 2022 DEFA14A
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 8-K
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 4
4 Apr, 2022 4
23 Mar, 2022 4
11 Mar, 2022 4
7 Mar, 2022 S-8
7 Mar, 2022 8-K
7 Mar, 2022 10-K
4 Mar, 2022 8-K
15 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G/A
7 Jan, 2022 4
7 Jan, 2022 4
7 Jan, 2022 4
7 Jan, 2022 4
7 Jan, 2022 4
16 Dec, 2021 SC 13G/A
14 Dec, 2021 8-K
22 Nov, 2021 EFFECT
18 Nov, 2021 CORRESP
17 Nov, 2021 UPLOAD
15 Nov, 2021 4
15 Nov, 2021 4
10 Nov, 2021 8-K
10 Nov, 2021 S-3
10 Nov, 2021 10-Q
14 Oct, 2021 SC 13G
8 Oct, 2021 8-K
8 Oct, 2021 424B5
8 Oct, 2021 424B5
7 Oct, 2021 424B5
7 Oct, 2021 424B5
5 Oct, 2021 4/A
4 Oct, 2021 4
4 Oct, 2021 4
4 Oct, 2021 4
4 Oct, 2021 4
21 Sep, 2021 8-K
14 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 3
1 Sep, 2021 8-K
31 Aug, 2021 S-8
27 Aug, 2021 3
27 Aug, 2021 4
19 Aug, 2021 4
17 Aug, 2021 8-K
12 Aug, 2021 8-K
12 Aug, 2021 10-Q
12 Aug, 2021 SC 13D/A
30 Jul, 2021 4
30 Jul, 2021 4
20 Jul, 2021 8-K
19 Jul, 2021 3
6 Jul, 2021 3
1 Jul, 2021 8-K CEO Change
24 Jun, 2021 4
24 Jun, 2021 8-K
24 Jun, 2021 4
24 Jun, 2021 4
24 Jun, 2021 4
24 Jun, 2021 4
24 Jun, 2021 4
24 Jun, 2021 4
17 May, 2021 8-K
13 May, 2021 8-K
13 May, 2021 10-Q
28 Apr, 2021 DEF 14A
28 Apr, 2021 DEFA14A
6 Apr, 2021 8-K
5 Apr, 2021 424B5
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 8-K
19 Mar, 2021 4
19 Mar, 2021 4
19 Mar, 2021 4
19 Mar, 2021 4
19 Mar, 2021 4
19 Mar, 2021 4
8 Mar, 2021 SC 13G/A
5 Mar, 2021 SC 13G
25 Feb, 2021 10-K
25 Feb, 2021 8-K
25 Feb, 2021 S-8
16 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
25 Jan, 2021 4
25 Jan, 2021 4
25 Jan, 2021 8-K
25 Jan, 2021 3
25 Jan, 2021 3
Last update:2025-03-06 13:18:13.520936
Cidara Therapeutics, Inc. by TradingView

Sign Up to Subscribe